Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Oncology Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8704275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetic resistance to anticancer agents

  2004cited by this paper
• Acute Induction of Adriamycin‐resistance in Human Colon Carcinoma HT‐29 Cells Exposed to a Sublethal Dose of Adriamycin

  1995cited by this paper
• Generation of a Mammalian Cell Line Deficient in Glucose-regulated Protein Stress Induction through Targeted Ribozyme Driven by a Stress-inducible Promoter (*)

  1995cited by this paper
• Increased cytotoxicity of chronic hypoxic cells by molecular inhibition of GRP78 induction.

  1994cited by this paper
• Induction of M(r) 78,000 glucose-regulated stress protein in poly(adenosine diphosphate-ribose) polymerase- and nicotinamide adenine dinucleotide-deficient V79 cell lines and its relation to resistance to the topoisomerase II inhibitor etoposide.

  1994cited by this paper
• Establishment of a chinese hamster ovary cell line that expresses grp78 antisense transcripts and suppresses A23187 induction of both GRP78 and GRP94

  1992cited by this paper
• Protein folding in the cell

  1992cited by this paper
• Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment

  1992cited by this paper
• Confluence‐dependent resistance in human colon cancer cells: Role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells

  1992cited by this paper
• Resistance mechanisms to topoisomerase poisons: the application of cell culture methods.

  1992cited by this paper
• Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance.

  1991cited by this paper
• DNA topoisomerase dysfunction: A new goal for antitumor chemotherapy

  1990cited by this paper
• A model for tumor cell killing by topoisomerase poisons.

  1990cited by this paper
• The ERD2 gene determines the specificity of the luminal ER protein retention system.

  1990cited by this paper
• ERD2, a yeast gene required for the receptor-mediated retrieval of luminal ER proteins from the secretory pathway.

  1990cited by this paper
• Mechanisms of resistance of confluent human and rat colon cancer cells to anthracyclines: alteration of drug passive diffusion.

  1990cited by this paper
• Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress response

  1989cited by this paper
• DNA topoisomerase poisons as antitumor drugs.

  1989cited by this paper
• Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells.

  1989cited by this paper
• Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.

  1988cited by this paper
• Complex regulation of heat shock- and glucose-responsive genes in human cells

  1988cited by this paper
• Cell and environment interactions in tumor microregions: the multicell spheroid model.

  1988cited by this paper
• Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells.

  1988cited by this paper
• Topoisomerase-specific drug sensitivity in relation to cell cycle progression

  1987cited by this paper
• A C-terminal signal prevents secretion of luminal ER proteins.

  1987cited by this paper
• Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells.

  1987cited by this paper
• The glucose-regulated protein grp94 is related to heat shock protein hsp90.

  1987cited by this paper
• Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomas.

  1987cited by this paper
• Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells.

  1987cited by this paper
• Importance of critical metabolites and cellular interactions in the biology of microregions of tumors

  1986cited by this paper
• Calcium ionophore A23187 as a regulator of gene expression in mammalian cells

  1986cited by this paper
• An Hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein.

  1986cited by this paper
• Topoisomerase II: A specific marker for cell proliferation

  1986cited by this paper
• DNA topoisomerases.

  1985cited by this paper
• Differential induction of glucose‐regulated and heat shock proteins: Effects of pH and sulfhydryl‐reducing agents on chicken embryo cells

  1985cited by this paper
• Induction of glucose-regulated proteins during anaerobic exposure and of heat-shock proteins after reoxygenation.

  1984cited by this paper
• Structural analysis of chicken oviduct progesterone receptor using monoclonal antibodies to the subunit B protein.

  1984cited by this paper
• Biochemical characterization of the mammalian stress proteins and identification of two stress proteins as glucose- and Ca2+-ionophore-regulated proteins.

  1983cited by this paper
• The accumulation of three specific proteins related to glucose‐regulated proteins in a temperature‐sensitive hamster mutant cell line K12

  1981cited by this paper
• DNA topoisomerases.

  1981cited by this paper
• Identification of the glucose/glycosylation‐regulated proteins as those which accumulate in the temperature‐sensitive cell line K12

  1981cited by this paper
• Glycoprotein synthesis in a temperature‐sensitive Chinese hamster cell cycle mutant

  1977cited by this paper
• Induction of two transformation-sensitive membrane polypeptides in normal fibroblasts by a block in glycoprotein synthesis or glucose deprivation.

  1977cited by this paper

• Glucose limitation protects cancer cells from apoptosis induced by pyrimidine restriction and replication inhibition

  2024cites this paper
• Pancastatin A and B have selective cytotoxicity on glucose-deprived PANC-1 human pancreatic cancer cells.

  2020cites this paper
• Pancastatin A and B Have Selective Cytotoxicity on Glucose-Deprived PANC-1 Human Pancreatic Cancer Cells

  2020cites this paper
• Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling

  2019cites this paper
• Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre

  2019cites this paper
• Hypoxia in Tumor Microenvironment and Chemotherapy Resistance

  2018cites this paper
• Herbs or Natural Products That Increase Cancer Growth or Recurrence

  2018cites this paper
• Phosphorylated Akt Protein at Ser473 Enables HeLa Cells to Tolerate Nutrient-Deprived Conditions

  2017cites this paper
• Complementary and alternative medicine use by cancer patients commencing curative-intent chemotherapy: survey and educational intervention

  2016cites this paper
• Proteomic approaches for identifying new mechanisms of action and pharmacodynamic biomarkers of resveratrol in colorectal cancer

  2015cites this paper
• Hypoxia and hypoxia mimetic cooperate to counteract tumor cell resistance to glucose starvation preferentially in tumor cells with mutant p53.

  2014cites this paper
• The unfolded protein response as a target for cancer therapy.

  2014cites this paper
• Why do some cancer patients receiving chemotherapy choose to take complementary and alternative medicines and what are the risks?

  2014cites this paper
• Interface entre glicosilação pós-traducional e estresse de retículo em melanomas: alvo para sensibilização de células tumorais a agentes quimioterápicos?

  2013cites this paper
• Design, synthesis, pharmacokinetics and pharmacodynamics of glucosamine related compounds for the treatment of arthritis

  2013cites this paper
• Role of Prostate Apoptosis Response 4 in Translocation of GRP78 from the Endoplasmic Reticulum to the Cell Surface of Trophoblastic Cells

  2013cites this paper
• Möglichkeiten der Überwindung von Chemoresistenz beim kindlichen Rhabdomyosarkom

  2013cites this paper
• Absorption and bioavailability of glucosamine in the rat.

  2012cites this paper
• UPR-Induced Resistance to Etoposide Is Downstream of PERK and Independent of Changes in Topoisomerase IIα Levels

  2012cites this paper
• Synthesis and Evaluation of Anticancer Natural Product Analogues Based on Angelmarin: Targeting the Tolerance towards Nutrient Deprivation

  2012cites this paper
• Metabolic utilization of exogenous pyruvate by mutant p53 (R175H) human melanoma cells promotes survival under glucose depletion

  2011cites this paper
• Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis.

  2011influential citation
• Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.

  2011cites this paper
• Sugar-free approaches to cancer cell killing

  2011cites this paper
• Dietary influences on mutagenesis—Where is this field going?

  2010cites this paper
• Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity

  2010cites this paper
• Regulation of DNA topoisomerase IIalpha stability by the ECV ubiquitin ligase complex.

  2009cites this paper
• The E3 Ubiquitin-Ligase Bmi1/Ring1A Controls the Proteasomal Degradation of Top2α Cleavage Complex – A Potentially New Drug Target

  2009influential citation
• Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78

  2009cites this paper
• A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines.

  2009cites this paper
• Prediction of drug response in breast cancer using integrative experimental/computational modeling.

  2009cites this paper
• Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1

  2009cites this paper
• The Role of Autophagy and Apoptosis in the Drug Resistance of Cancer

  2009cites this paper
• The Unfolded Protein Response Increases Production of Pro-Angiogenic Factors by Tumor Cell Lines

  2008cites this paper
• The multifactorial nature of hypoxia-induced drug resistance in cancer: involvement of hypoxia-inducible factor 1

  2008cites this paper
• Tetramic and tetronic acids: an update on new derivatives and biological aspects.

  2008cites this paper
• OASIS AND XBP-1 ACTIVITY IN OSTEOBLAST DIFFERENTIATION AND OSTEOSARCOMA

  2008cites this paper
• The analysis of chemotherapy resistance in human lung cancer cell line with microchip-based system

  2008cites this paper
• Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.

  2008cites this paper
• Etoposide‐resistant HT‐29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down‐regulator

  2008cites this paper
• Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival.

  2007cites this paper
• Mithramycin inhibits etoposide resistance in glucose-deprived HT-29 human colon carcinoma cells.

  2007cites this paper
• Glucose-deprived HT-29 human colon carcinoma cells are sensitive to verrucosidin as a GRP78 down-regulator.

  2007cites this paper
• Unfolded Protein Response: Contributions to Development and Disease

  2007cites this paper
• Drug resistance and the solid tumor microenvironment.

  2007cites this paper
• Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway.

  2006cites this paper
• Proteomic analysis of neuroblastoma subtypes in response to mitogen-activated protein kinase inhibition: profiling multiple targets of cancer kinase signaling.

  2006cites this paper
• Overexpression of glucose-regulated protein 78 in colon cancer.

  2006cites this paper
• Stress induction of GRP78/BiP and its role in cancer.

  2006cites this paper
• UPR activation alters chemosensitivity of tumor cells

  2006cites this paper
• Microenvironment Drug Resistance Effector GRP 78 within the Tumor Vascular Targeting and Antiangiogenesis Agents Induce

  2005cites this paper
• Up‐regulation of 94‐kDa glucose‐regulated protein by hypoxia‐inducible factor‐1 in human endothelial cells in response to hypoxia

  2005cites this paper
• Activation of the Unfolded Protein Response Is Necessary and Sufficient for Reducing Topoisomerase IIα Protein Levels and Decreasing Sensitivity to Topoisomerase-Targeted Drugs

  2005influential citation
• Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.

  2005cites this paper
• Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts.

  2005cites this paper
• Herbs or natural products that increase cancer growth or recurrence. Part two of a four-part series.

  2004cites this paper
• Effect on tumor cells of blocking survival response to glucose deprivation.

  2004cites this paper
• Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions

  2004cites this paper
• Interaction between Glucose-regulated Destruction Domain of DNA Topoisomerase IIα and MPN Domain of Jab1/CSN5*

  2004cites this paper
• The role of the unfolded protein response in tumour development: friend or foe?

  2004cites this paper
• Biosynthetic studies of versipelostatin, a novel 17-membered α-tetronic acid involved macrocyclic compound isolated from Streptomyces versipellis

  2003cites this paper
• Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase Inhibitors

  2003cites this paper
• Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal

  2003cites this paper
• Recurrent growth factor starvation promotes drug resistance in human leukaemic cells

  2002cites this paper
• DRUG RESISTANCE PATHWAYS AS TARGETS

  2002cites this paper
• Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line.

  2001cites this paper
• Characterization of cell lines resistant to topoisomerase targeting drugs and mechanistic studies of Quinoxaline solid tumor drugs - a new chemical class of topoisomerase II poisons /

  2001cites this paper
• ATP-bound Topoisomerase II as a Target for Antitumor Drugs*

  2001cites this paper
• Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.

  2000cites this paper
• Cellular sensitization to cisplatin and carboplatin with decreased removal of platinum-DNA adduct by glucose-regulated stress

  1999cites this paper
• Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas.

  1999cites this paper
• Dietary restriction and 2‐deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: Evidence for a preconditioning mechanism

  1999cites this paper
• Glucose starvation and hypoxia induce nuclear accumulation of proteasome in cancer cells.

  1999cites this paper
• Dietary restriction and 2‐deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease

  1999cites this paper
• 2‐deoxy‐d‐glucose protects hippocampal neurons against excitotoxic and oxidative injury: Evidence for the involvement of stress proteins

  1999cites this paper
• Drug resistance mediated by cellular stress response to the microenvironment of solid tumors.

  1999cites this paper
• Glucose‐regulated stresses cause degradation of DNA topoisomerase IIα by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells

  1999cites this paper
• adapt78, a stress-inducible mRNA, is related to the glucose-regulated protein family of genes.

  1999cites this paper
• Down‐regulation of epidermal growth factor receptor‐signaling pathway by binding of GRP78/BiP to the receptor under glucose‐starved stress conditions

  1998cites this paper
• Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy

  1998cites this paper
• A Novel Mutant from Apoptosis‐resistant Colon Cancer HT‐29 Cells Showing Hyper‐apoptotic Response to Hypoxia, Low Glucose and Cisplatin

  1998cites this paper
• The Role of an Inverted CCAAT Element in Transcriptional Activation of the Human DNA Topoisomerase IIα Gene by Heat Shock*

  1998cites this paper
• Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death.

  1998cites this paper
• 2‐deoxyglucose inhibits chemotheapeutic drug‐induced apoptosis in human monocytic leukemia U937 cells ith inhibition of c‐Jun N‐terminal kinase 1/stress‐activated protein kinase activation

  1998cites this paper
• Differential actions of aclarubicin and doxorubicin: the role of topoisomerase I.

  1997cites this paper
• A DNA-topoisomerase-II-binding protein with eight repeating regions similar to DNA-repair enzymes and to a cell-cycle regulator.

  1997cites this paper
• Glucose‐regulated stresses induce resistance to camptothecin in human cancer cells

  1996cites this paper
• Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells.

  1996cites this paper